Remember Me     Forgot Login?   Sign up   •  Web site Help & Info

!!! DISCUSSION GROUP RULES !!!

1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!

Research Trial

More
9 years 4 months ago #57231 by meredithjane
Research Trial was created by meredithjane
Was recently given information about a research trial involving UCB7665 - (sponsor UCB Biopharma SPRL). It is an antibody that aims to lower levels of Immunoglobulin G.
Seems the trial is happening in Europe, UK & Australia. Is anyone here involved?
Not sure if I qualify as counts need to be stable <30> & it would mean weekly trips to city, 2.5 hours away.
mj

Please Log in or Create an account to join the conversation.

More
9 years 4 months ago - 9 years 4 months ago #57235 by rjsmyth
Replied by rjsmyth on topic Research Trial
Search for this thread here and move towards the end:

nplate-loss-of-effectiveness

Please Log in or Create an account to join the conversation.

You’re not alone. We have answers!
Contact PDSA to connect with life altering information, resources and referrals. 440.746.9003 (877.528.3538 toll-free) or pdsa@pdsa.org.

Platelet Disorder Support Association

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003  |  pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.

IMPORTANT!

The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.